CD40LG and autoimmune disease: Therefore, the findings and experience with anti-CD40/CD154 clinical trials studied in patients with different autoimmune diseases, not limited to autoimmune arthritis, remain valuable for obtaining more solid information regarding the efficacy, mechanism and safety issues of anti-CD40/CD154 treatment in humans.